在关节关节整形术中使用 Melatonin:对随机临床研究的批判性系统审查
Ayman K Saleh1,2, Hany Said Ismail Ramadan3, Saeed Mostafa Abdelhameed3
1Department of Surgery, College of Medicine, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Journal of pain & palliative care pharmacotherapy
|April 12, 2025
概括
这次审查考察了黑激素.
科学领域:
- 整形外科手术 整形外科手术
- 药理学 药理学是指药理学的学科.
背景情况:
- 关节关节整形术是常见的.
- 手术后的并发症包括疼痛,妄想和睡眠障碍.
研究的目的:
- 系统地审查关节关节整形术患者的外科手术期间的黑激素随机临床研究.
主要方法:
- 按照PRISMA指南进行系统审查.
- 分析了8项随机临床研究.
- 对疼痛,睡眠质量和妄想的评估影响.
主要成果:
- 黑色素在治疗术后疼痛,睡眠障碍和妄想方面表现出不同程度的成功.
- 六项研究评估了疼痛和睡眠;两项研究评估了妄想.
结论:
- 目前关于黑激素在治疗关节关节整形术并发症方面的疗效的证据并不强大.
- 需要进一步进行高质量的临床研究.
相关概念视频
Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...


